<code id='A4842E0F4A'></code><style id='A4842E0F4A'></style>
    • <acronym id='A4842E0F4A'></acronym>
      <center id='A4842E0F4A'><center id='A4842E0F4A'><tfoot id='A4842E0F4A'></tfoot></center><abbr id='A4842E0F4A'><dir id='A4842E0F4A'><tfoot id='A4842E0F4A'></tfoot><noframes id='A4842E0F4A'>

    • <optgroup id='A4842E0F4A'><strike id='A4842E0F4A'><sup id='A4842E0F4A'></sup></strike><code id='A4842E0F4A'></code></optgroup>
        1. <b id='A4842E0F4A'><label id='A4842E0F4A'><select id='A4842E0F4A'><dt id='A4842E0F4A'><span id='A4842E0F4A'></span></dt></select></label></b><u id='A4842E0F4A'></u>
          <i id='A4842E0F4A'><strike id='A4842E0F4A'><tt id='A4842E0F4A'><pre id='A4842E0F4A'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:842
          Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT
          Darron Cummings/AP

          The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

          Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

          advertisement

          MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit
          Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

          CraigF.Walker/TheBostonGlobeMaryBrownwassippingcoffeeathomeinOntario,Calif.,Sundaymorningwhenafriend

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Newly revealed memo details efforts to keep Trump in power following election loss

          2:14PresidentDonaldTrumpspeakstosupportersfromTheEllipseneartheWhiteHouseonJanuary6,2021,inWashingto